CD274 and cancer: Despite the fact that the uncovered mechanisms of these experiments are different and the relationship between PDK and PD-L1 is inconsistent, intriguingly, they both demonstrate co-treatment with the PDK inhibitor and anti-PD-L1 antibody in vivo show better anti-cancer effect67-69.